CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2

Cachorro, E; Guenscht, M; Schubert, M; Sadek, MS; Siegert, J; Dutt, F; Bauermeister, C; Quickert, S; Berning, H; Nowakowski, F; Laemmle, S; Firneburg, R; Luo, XJ; Künzel, SR; Klapproth, E; Mirtschink, P; Mayr, M; Dewenter, M; Vettel, C; Heijman, J; Lorenz, K; Guan, KM; El-Armouche, A; Wagner, M; Kämmerer, S

El-Armouche, A (通讯作者),Tech Univ Dresden, Inst Pharmakol & Toxikol, Dresden, Germany.

CIRCULATION RESEARCH, 2023; 132 (4): 400

Abstract

Background:Ventricular arrhythmia and sudden cardiac death are the most common lethal complications after myocardial infarction. Antiarrhythmic pharma......

Full Text Link